Ruth L. Ladenstein

St. Anna Children's Hospital
Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 153 publications

Long-Term Analysis of Patients With Ewing Sarcoma Included in the Euro-EWING99 Study.

Long-Term Analysis of Patients With Ewing Sarcoma Included in the Euro-EWING99 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 31, 2026

Association Between Dinutuximab Beta Exposure and Post-End-of-Treatment Survival in Neuroblastoma: A Weighted Patient-Level Analysis of Three Clinical Studies.

Association Between Dinutuximab Beta Exposure and Post-End-of-Treatment Survival in Neuroblastoma: A Weighted Patient-Level Analysis of Three Clinical Studies.

Journal: Pediatric blood & cancer

Published: May 10, 2026

The Survivorship Passport for childhood cancer survivors: improvements and experience within several European PanCare projects.

The Survivorship Passport for childhood cancer survivors: improvements and experience within several European PanCare projects.

Journal: Journal of cancer survivorship : research and practice

Published: April 21, 2026

European Reference Networks as core health structures where referring genetic newborn screening positive infants: an innovative operational research framework.

European Reference Networks as core health structures where referring genetic newborn screening positive infants: an innovative operational research framework.

Journal: Frontiers in public health

Published: March 03, 2026

Crisis readiness for rare disease populations: learnings and recommendations by the European Reference Networks.

Crisis readiness for rare disease populations: learnings and recommendations by the European Reference Networks.

Journal: The Lancet regional health. Europe

Published: February 25, 2026

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 12, 2025

European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025.

European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025.

Journal: Orphanet journal of rare diseases

Published: December 03, 2025

Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons.

Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons.

Journal: Frontiers in oncology

Published: October 30, 2025

Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison.

Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison.

Journal: Cancers

Published: July 24, 2025

Children and Adolescents With Localised Non-Rhabdomyosarcoma Soft Tissue Sarcoma: Results of the CWS-96 and CWS-2002P Prospective Trials With Reclassification of the Trial Data Incorporating the Recent Soft Tissue Sarcoma Registry.

Children and Adolescents With Localised Non-Rhabdomyosarcoma Soft Tissue Sarcoma: Results of the CWS-96 and CWS-2002P Prospective Trials With Reclassification of the Trial Data Incorporating the Recent Soft Tissue Sarcoma Registry.

Journal: Pediatric blood & cancer

Published: June 19, 2025

Inequalities in availability of clinical trials for pediatric, adolescent, and young adult patients with cancer in Europe: results from the SIOPE OCEAN project.

Inequalities in availability of clinical trials for pediatric, adolescent, and young adult patients with cancer in Europe: results from the SIOPE OCEAN project.

Journal: The Lancet regional health. Europe

Published: June 04, 2025

Sensitive detection of minimal residual disease and immunotherapy targets by multi-modal bone marrow analysis in high-risk neuroblastoma - a multi-center study.

Sensitive detection of minimal residual disease and immunotherapy targets by multi-modal bone marrow analysis in high-risk neuroblastoma - a multi-center study.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 29, 2025

Showing 1-12 of 153

Last Updated: 09/26/2026